Bland AE - Search Results

1

Evaluation of two management strategies for preoperative grade 1 endometrial cancer.

Bernardini MQ, May T, Khalifa MA, Bland AE, Nofech-Mozes S, Berchuck A, Covens A, Havrilesky L. Bernardini MQ, et al. Among authors: bland ae. Obstet Gynecol. 2009 Jul;114(1):7-15. doi: 10.1097/AOG.0b013e3181aa97fc. Obstet Gynecol. 2009. PMID: 19546752

2

The role of lymphadenectomy in the management of preoperative grade 1 endometrial carcinoma.

Neubauer NL, Havrilesky LJ, Calingaert B, Bulusu A, Bernardini MQ, Fleming ND, Bland AE, Secord AA. Neubauer NL, et al. Among authors: bland ae. Gynecol Oncol. 2009 Mar;112(3):511-6. doi: 10.1016/j.ygyno.2008.11.012. Epub 2009 Jan 13. Gynecol Oncol. 2009. PMID: 19144394

3

The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.

Alvarez Secord A, Havrilesky LJ, Bae-Jump V, Chin J, Calingaert B, Bland A, Rutledge TL, Berchuck A, Clarke-Pearson DL, Gehrig PA. Alvarez Secord A, et al. Gynecol Oncol. 2007 Nov;107(2):285-91. doi: 10.1016/j.ygyno.2007.06.014. Epub 2007 Aug 6. Gynecol Oncol. 2007. PMID: 17688923

4

Analgesic and antiemetic needs following minimally invasive vs open staging for endometrial cancer.

Fleming ND, Havrilesky LJ, Valea FA, Allen TK, Broadwater G, Bland A, Habib AS. Fleming ND, et al. Am J Obstet Gynecol. 2011 Jan;204(1):65.e1-6. doi: 10.1016/j.ajog.2010.08.020. Am J Obstet Gynecol. 2011. PMID: 20869036

5

Relationship between tamoxifen use and high risk endometrial cancer histologic types.

Bland AE, Calingaert B, Secord AA, Lee PS, Valea FA, Berchuck A, Soper JT, Havrilesky L. Bland AE, et al. Gynecol Oncol. 2009 Jan;112(1):150-4. doi: 10.1016/j.ygyno.2008.08.035. Epub 2008 Oct 19. Gynecol Oncol. 2009. PMID: 18937966

6

Robotic-assisted laparoscopic gynecologic procedures in a fellowship training program.

Lee PS, Bland A, Valea FA, Havrilesky LJ, Berchuck A, Secord AA. Lee PS, et al. JSLS. 2009 Oct-Dec;13(4):467-72. doi: 10.4293/108680809X12589998403921. JSLS. 2009. PMID: 20202385 Free PMC article.

7

Elevated MAL expression is accompanied by promoter hypomethylation and platinum resistance in epithelial ovarian cancer.

Lee PS, Teaberry VS, Bland AE, Huang Z, Whitaker RS, Baba T, Fujii S, Secord AA, Berchuck A, Murphy SK. Lee PS, et al. Among authors: bland ae. Int J Cancer. 2010 Mar 15;126(6):1378-89. doi: 10.1002/ijc.24797. Int J Cancer. 2010. PMID: 19642140 Free article.

8

Cyclin E overexpression in epithelial ovarian cancer characterizes an etiologic subgroup.

Schildkraut JM, Moorman PG, Bland AE, Halabi S, Calingaert B, Whitaker R, Lee PS, Elkins-Williams T, Bentley RC, Marks JR, Berchuck A. Schildkraut JM, et al. Among authors: bland ae. Cancer Epidemiol Biomarkers Prev. 2008 Mar;17(3):585-93. doi: 10.1158/1055-9965.EPI-07-0596. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18349276

9

A clinical and biological comparison between malignant mixed müllerian tumors and grade 3 endometrioid endometrial carcinomas.

Bland AE, Stone R, Heuser C, Shu J, Jazaeri A, Shutter J, Atkins K, Rice L. Bland AE, et al. Int J Gynecol Cancer. 2009 Feb;19(2):261-5. doi: 10.1111/IGC.0b013e31819a1fa5. Int J Gynecol Cancer. 2009. PMID: 19396006

10

Predictors of suboptimal surgical cytoreduction in women with advanced epithelial ovarian cancer treated with initial chemotherapy.

Bland AE, Everett EN, Pastore LM, Andersen WA, Taylor PT Jr. Bland AE, et al. Int J Gynecol Cancer. 2008 Jul-Aug;18(4):629-36. doi: 10.1111/j.1525-1438.2007.01114.x. Epub 2007 Nov 6. Int J Gynecol Cancer. 2008. PMID: 17986246

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17 results

Search Page